ISOTRETINOIN (13-CIS-RETINOIC ACID) METABOLISM, CIS-TRANS ISOMERIZATION, GLUCURONIDATION, AND TRANSFER TO THE MOUSE EMBRYO - CONSEQUENCES FOR TERATOGENICITY
ISOTRETINOIN (13-CIS-RETINOIC ACID) METABOLISM, CIS-TRANS ISOMERIZATION, GLUCURONIDATION, AND TRANSFER TO THE MOUSE EMBRYO - CONSEQUENCES FOR TERATOGENICITY
复制标题
DOI：
10.1002/tcm.1770110104
复制
发表时间：
1991-01-01
期刊：
影响因子：
--
通讯作者：
NAU, H
中科院分区：
文献类型：
--
作者：
KRAFT, JC;ECKHOFF, C;NAU, H
It has been reported that fractionated doses of 13-cis-retinoic acid are disproportionately more embryotoxic in pregnant mice than is the same dose given in a single bolus. Here, we examined limited pharmacokinetic profiles of a single (100 mg/kg dose given to NMRI mice on day 11 of gestation) versus multiple (3 X 100 mg/kg, 4 h apart) doses in an effort to assess the relative contribution to teratogenicity made by the drug and/or its metabolites. The major plasma metabolite of 13-cis-retinoic acid in the mouse was 13-cis-retinoyl-beta-glucuronide, followed by the 4-oxo metabolites and all-trans-retinoic acid. Transfer to the mouse embryo was very efficient for all-trans-retinoic acid, whereas, it was tenfold less efficient for 13-cis-retinoic acid and 100-fold less efficent for 13-cis-retinoyl-beta-glucuronide. The isomer all-trans-retinoic acid was found in the placenta at concentrations two-to three-fold higher than in the plasma, suggesting placental accumulation as well as placental cis/trans isomerization. Since 13-cis-retinoyl-beta-glucuronide and 13-cis- and all-trans-retinoic acid were detected in the embryo after this multiple dosing schedule, any of the three or their combinations may have been involved in the induction of malformations, but all-trans-retinoic acid, a well-known potent teratogen detected at concentrations of between 590 and 80 ng/g for 10 critical hours during gestation, could have been the major component.
